Allergy Therapeutics
Manufacturing · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Allergy Therapeutics Dominion Way, Worth...Phone Number
+44 1904000000Website
www.allergytherapeutics.comRevenue
$75.2 MillionStock Symbol
AGYIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Allergy Therapeutics
Allergy Therapeutics was founded in 1999 and is headquartered in Worthing, United Kingdom, an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminum-free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in European countries and via distribution agreements in additional countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in preclinical development.Explore more
Allergy Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allergy Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Allergy Therapeutics has new funding data
Click to see if Allergy Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Allergy Therapeutics is spiking on competitors!
Product Launch: Get notified when Allergy Therapeutics launches new products
Earning: See what the market has to say on Allergy Therapeutics recently announced quarterly report
Check if Allergy Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Allergy Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Allergy Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Allergy Therapeutics
Compare insights from companies similar to Allergy Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Allergy Therapeutics
$75.2M
501-1,000
Public
$50.8M
1998
Helge Weiner-TrapnessChief Strategy Officer & Executive Director
Company Profile Activity
Activity Insights
Allergy Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allergy Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allergy Therapeutics.
Allergy Therapeutics financials insights
Gather financial insights about Allergy Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Debt
$50.8M
Allergy Therapeutics Tech Stack
A closer look at the technologies used by Allergy Therapeutics
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Events, Medical Research, Clinical Operations
Person-Based
Executive Move
Executive Moves, Board of Directors
Allergy Therapeutics News & Media
REG - Allergy Therapeutics - Chief Strategy Officer and Board appointments - TradingView
RNS Number : 0877R Allergy Therapeutics PLC 30 January 2026 Allergy Therapeutics plc("Allergy Therapeutics" or the "Company" or "Group")Allergy Therapeutics announces the appointments of Helge Weiner-Trapness as Chief Strategy Officer and Executive Director, and Lawrence Allen Wang as Independe…Allergy Therapeutics (LON:AGY) shareholders have earned a 65% return over the last year
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...Investors in Allergy Therapeutics (LON:AGY) have seen impressive returns of 143% over the past year
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allergy Therapeutics
Sign Up For FreeTo access detailed company insights
Allergy Therapeutics was founded in 1999 and is headquartered in Worthing, United Kingdom, an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminum-free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from... Read More
